Principal Financial Group
PMVP icon

Principal Financial Group’s PMV Pharmaceuticals PMVP Stock Holding History

Principal Financial Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,180
Closed -$24.1K – 2434
2024
Q1 		$24.1K Sell
14,180
-1,436
-9% -$2.68K ﹤0.01% 2395
2023
Q4 		$48.4K Sell
15,616
-903,526
-98% -$2.39M ﹤0.01% 2333
2023
Q3 		$5.64M Sell
919,142
-7,593
-0.8% -$52.2K ﹤0.01% 1490
2023
Q2 		$5.8M Buy
926,735
+8,850
+1% +$46.4K ﹤0.01% 1477
2023
Q1 		$4.38M Buy
917,885
+22,019
+2% +$155K ﹤0.01% 1577
2022
Q4 		$7.79M Sell
895,866
-52,010
-5% -$554K 0.01% 1373
2022
Q3 		$11.3M Buy
947,876
+126,644
+15% +$1.83M 0.01% 1121
2022
Q2 		$11.7M Buy
821,232
+202,306
+33% +$2.94M 0.01% 1165
2022
Q1 		$12.9M Buy
618,926
+21,964
+4% +$387K 0.01% 1232
2021
Q4 		$13.8M Buy
596,962
+107,027
+22% +$2.59M 0.01% 1214
2021
Q3 		$14.6M Buy
489,935
+28,022
+6% +$895K 0.01% 1176
2021
Q2 		$15.8M Buy
461,913
+263,491
+133% +$8.8M 0.01% 1159
2021
Q1 		$6.53M Buy
198,422
+1,967
+1% +$77.5K ﹤0.01% 1572
2020
Q4 		$12.1M Sell
196,455
-4,345
-2% -$170K 0.01% 1117
2020
Q3 		$7.13M Buy
+200,800
New +$7.39M 0.01% 1280

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Principal Financial Group's PMVP Position: Q2 2024 in Review

Principal Financial Group sold out of PMV Pharmaceuticals (PMVP) in Q2 2024, closing a stake of 14,180 shares — an estimated $24.1K sold.

Principal Financial Group first reported a position in PMVP in Q3 2020 and held it in 15 quarters. The position peaked at $15.8M in Q2 2021. 93 funds tracked by Wall St. Rank hold PMVP as of Q2 2024.

  • Principal Financial Group reported no remaining PMV Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 14,180 PMV Pharmaceuticals shares in Q2 2024, an estimated $24.1K.
  • Principal Financial Group first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 15 quarters.
  • Principal Financial Group's PMV Pharmaceuticals position peaked at $15.8M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.